Royalty Pharma Plc (RPRX)

Royalty Pharma Plc Stock (RPRX) Forecast

The Royalty Pharma Plc (RPRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $67.31, representing a -3.09% decrease from the current price of $69.46. The highest analyst price target is $69.27, and the lowest is $65.36.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month RPRX Price Target

Average 70.72 (+1.81% Downside)

Is Royalty Pharma Plc (RPRX) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	74.13	Sell
STOCH(9,6)	80.12	Sell
STOCHRSI(14)	40.00	Neutral
MACD(12,26)	2.51	Buy
ADX(14)	39.02	Buy
William %R	-14.31	Sell
CCI(14)	50.78	Neutral

Buy: 2 · Sell: 3 · Neutral: 2Summary: Sell

Moving Averages

Period	Simple	Exponential
MA10	68.01 Buy	67.93 Buy
MA20	65.71 Buy	65.91 Buy
MA50	61.41 Buy	62.72 Buy
MA100	59.99 Buy	59.83 Buy
MA200	54.49 Buy	54.79 Buy

Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, RPRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on RPRX, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 74.13 indicates that RPRX is overbought. This suggests that RPRX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
STOCH (Stochastic Oscillator): The STOCH value of 80.12 indicates that RPRX is overbought. This means that RPRX price is at or near the highest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.00 indicates that RPRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 39.02 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 50.78 indicates that RPRX is still overbought but not to an extreme extent.

Long-term RPRX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Royalty Pharma Plc financial reports and earnings history, Royalty Pharma Plc (RPRX) stock could reach $79.07 by 2030, $144.08 by 2040 and $207.52 by 2050. See the projected annual prices until 2050 of the Royalty Pharma Plc stock below:

Royalty Pharma Plc (RPRX) is expected to reach an average price of $106.71 in 2035, with a high prediction of $108.63 and a low estimate of $101.77. This indicates an +53.63% change from the last recorded price of $69.46.
Royalty Pharma Plc (RPRX) stock is projected to chart a bullish course in 2040, with an average price target of $142.87, representing an +105.69% change from its current level. The forecast ranges from a conservative $133.06 to a sky-high $144.08.
Our analysts predict Royalty Pharma Plc (RPRX) to change +145.29% by 2045, soaring from $167.58 to an average price of $170.38, potentially reaching $174.91. While $167.58 is the low estimate, the potential upside is significant.
Royalty Pharma Plc (RPRX) stock is expected to climb by 2050, reaching an average of $203.64, a +193.17% change from its current level. However, a wide range of estimates exists, with high and low targets of $207.52 and $188.89, respectively, highlighting the market's uncertainty.

Royalty Pharma Plc Stock (RPRX) Year by Year Forecast

Royalty Pharma Plc Stock (RPRX) Price Forecast for 2026

The predicted value for Royalty Pharma Plc (RPRX) in 2026 is set at an average of $56.72. Estimates vary from a peak of $72.13 to a trough of $38.29, indicating an -18.35% surge from the present price of $69.46.

Month	Average	Low	High	Change from today's price
December, 2026	$69.10	$65.36	$69.27	-0.52%

Royalty Pharma Plc Stock (RPRX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Royalty Pharma Plc (RPRX) is $71.95, with a high forecast of $76.08 and a low forecast of $65.66. This indicates an +3.58% increase from the last price of $69.46.

Month	Average	Low	High	Change from today's price
January, 2027	$68.25	$67.01	$71.66	-1.74%
February, 2027	$69.23	$66.71	$70.53	-0.32%
March, 2027	$67.97	$65.66	$70.36	-2.14%
April, 2027	$69.33	$67.48	$69.82	-0.19%
May, 2027	$70.02	$68.99	$74.85	+0.80%
June, 2027	$71.70	$67.43	$72.23	+3.23%
July, 2027	$74.03	$68.20	$74.39	+6.57%
August, 2027	$74.39	$72.29	$75.60	+7.09%
September, 2027	$75.52	$73.46	$76.08	+8.73%
October, 2027	$75.31	$72.86	$75.57	+8.43%
November, 2027	$73.43	$71.48	$75.95	+5.71%
December, 2027	$74.22	$72.60	$75.46	+6.85%

Royalty Pharma Plc Stock (RPRX) Price Forecast for 2028

In 2028, Royalty Pharma Plc (RPRX) is projected to reach an average price of $68.69, with a high projection of $77.08 and a low estimate of $61.63. This indicates an -1.11% fall from the last price of $69.46.

Month	Average	Low	High	Change from today's price
January, 2028	$76.46	$73.96	$77.08	+10.08%
February, 2028	$72.39	$71.55	$76.33	+4.22%
March, 2028	$72.04	$70.84	$72.86	+3.71%
April, 2028	$71.24	$70.13	$72.52	+2.56%
May, 2028	$68.37	$66.41	$71.27	-1.57%
June, 2028	$70.26	$68.37	$72.05	+1.15%
July, 2028	$68.04	$67.00	$70.73	-2.05%
August, 2028	$67.49	$66.41	$69.24	-2.83%
September, 2028	$64.86	$63.99	$68.52	-6.62%
October, 2028	$65.78	$64.81	$66.73	-5.29%
November, 2028	$65.27	$64.29	$66.67	-6.04%
December, 2028	$62.04	$61.63	$66.18	-10.68%

Royalty Pharma Plc Stock (RPRX) Price Forecast for 2029

The 2029 price forecast for Royalty Pharma Plc Stock (RPRX) is $65.60 on average, with a high prediction of $69.08 and a low estimate of $61.89. This represents an -5.55% decrease from the previous price of $69.46.

Month	Average	Low	High	Change from today's price
January, 2029	$62.25	$61.89	$64.49	-10.38%
February, 2029	$62.91	$62.35	$64.71	-9.44%
March, 2029	$65.14	$62.85	$65.71	-6.22%
April, 2029	$65.28	$63.45	$66.27	-6.02%
May, 2029	$65.26	$64.81	$66.57	-6.04%
June, 2029	$67.77	$64.58	$69.08	-2.44%
July, 2029	$68.13	$66.78	$68.56	-1.92%
August, 2029	$66.02	$65.23	$68.37	-4.95%
September, 2029	$65.56	$65.53	$67.14	-5.62%
October, 2029	$65.53	$64.52	$66.25	-5.66%
November, 2029	$67.02	$64.01	$67.61	-3.51%
December, 2029	$66.38	$64.86	$68.14	-4.43%

Royalty Pharma Plc Stock (RPRX) Price Forecast for 2030

Royalty Pharma Plc Stock (RPRX) is expected to reach an average price of $71.74 in 2030, with a high forecast of $79.07 and a low forecast of $64.58. This signifies an +3.28% surge from the last price of $69.46.

Month	Average	Low	High	Change from today's price
January, 2030	$67.20	$66.51	$68.77	-3.26%
February, 2030	$67.49	$67.06	$68.28	-2.84%
March, 2030	$67.00	$66.88	$68.25	-3.54%
April, 2030	$66.99	$65.30	$68.50	-3.55%
May, 2030	$66.14	$64.58	$67.00	-4.78%
June, 2030	$71.61	$65.84	$71.95	+3.10%
July, 2030	$74.61	$70.65	$74.88	+7.42%
August, 2030	$75.16	$73.39	$75.46	+8.20%
September, 2030	$74.39	$71.38	$75.66	+7.09%
October, 2030	$75.20	$73.43	$76.16	+8.26%
November, 2030	$76.09	$74.30	$76.50	+9.55%
December, 2030	$79.01	$75.75	$79.07	+13.75%